Protocols for Leukemia and Lymphoma
| HIC 0611002061 Gary Kupfer Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) A Phase III Clinical Trial (COG ALL0331) |
| HIC 0704002570 Francine Foss M.D. A Phase II, Multicenter, Open-Label Trial Evaluating The Activity And Tolerability Of Romidepsin (Depsipeptide, FK228) in Progressive Peripheral T-Cell Lymphoma Following Prior Systemic Therapy |
| HIC 0901004690 Francine Foss M.D. A Pilot Biomarker Study of Sorafenib in Relapsed or Refractory T-cell Lymphoma |
| HIC 0905005127 Mario Sznol M.D. A Phase 1, Multicenter, Opened-label, Dose-escalation, Multidose Study of MDX-1203 in Subects with Advanced/Recurrent Clear Cell Renal Cell Carcinoma or Relapsed/Refractory B-Cell Non-Hodgkin's Lympohoma |
| HIC 24475 Gary Kupfer COG AHOD0031: A Phase III Group-Wide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly diagnosed Intermediate Risk Hodgkin's Disease |
| HIC 0703002455 Stuart Seropian M.D. A Pilot Study of Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute Graft Versus Host Disease in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation |
| HIC 0506000158 Francine Foss M.D. A Phase I Dose Escalation Study of Clofarabine in Patients with Relapsed or Refractory Low Grade or Intermediate Grade B-Cell Lymphoma |
| HIC 26963 Dennis Cooper M.D. Randomized Control Trial of Insulin Pump Therapy for Patients Undergoing Bone Marrow Transplantation |
| HIC 0611002012 Gary Kupfer A Phase III Randomized Trial of Gemuzumab Ozogamicin Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents and Young Adults |
| HIC 0711003269 Francine Foss M.D. A Phase I/II Trial of Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas |
| HIC 0703002472 Peter Marks M.D.;Ph.D. A Phase I Clinical Trial of Vorinostat in Combination with Decitabine in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome |
| HIC 0706002745 Gary Kupfer Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies |
| HIC 0508000433 Francine Foss M.D. A Randomized Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation Versus Pentostatin and Total Body Irradiation in Patients Undergoing Allogeneic Stem Cell Transplantation for The Treatment of Hematologic Malignancies |
| HIC 0903004876 Francine Foss M.D. Open Label Multi-Center Dose Escalation Phase I/II Study of Anti-CCR4 Monoclonal Antibody KW-0761 as Monotherapy in Subjects With Previously Treated Peripheral T-Cell or Cutaneous T-cell Lymphoma |
| HIC 27692 Gary Kupfer COG AALL0232: High-Risk B-Precursor Acute Lymphoblastic Leukemia |
| HIC 0702002350 Stuart Seropian M.D. Rapamycin for Prevention of Chronic Graft-versus-Host Disease |
| HIC 0704002547 Gary Kupfer Intensified Methotrexate, Nelarabine (Compound 506U78; IND#52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) |